Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors (NCT05611307)

🧪 Interventions in This Study

• Lipid profile (DIAGNOSTIC_TEST)
• Coronary artery assessment (DIAGNOSTIC_TEST)
• Hormone levels for hypogonadism (DIAGNOSTIC_TEST)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Indiana University — Indianapolis, Indiana

📞 Contact the Study Coordinator

Phone: (317) 278-1185

Email: rowee@iu.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Testicular Cancer

• WATChmAN Virtual Testicular Cancer Clinic — Toronto, Ontario
• Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer — Indianapolis, Indiana
• Low-Dose CT - Stage I Testicular Cancer — Toronto, Ontario
• Virtual Testis Cancer Lay Support and Survivorship Aim 2 — Chapel Hill, North Carolina
• Patient Reported Experiences With Sparing External Oblique Fascia Vs Standard Inguinal Orchiectomy — Loma Linda, California
• Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection. — Indianapolis, Indiana

Explore by condition: All Testicular Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.